| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 18 |
| 1 | METHADONE | 7 |
| 2 | SOMATROPIN | 7 |
| 3 | CLOZAPINE | 4 |
| 4 | METHADONE HYDROCHLORIDE | 4 |
| 5 | MORPHINE | 4 |
| 6 | RISPERIDONE | 4 |
| 7 | TESTOSTERONE | 4 |
| 8 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 3 |
| 9 | GABAPENTIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIHYDROERGOTAMINE MESYLATE | 1 | 0.0007 |
| 1 | GAUNFACINE | 2 | 0.0005 |
| 2 | RYDAPT | 1 | 0.0005 |
| 3 | METHADONE HYDROCHLORIDE | 4 | 0.0004 |
| 4 | PRASTERONE | 1 | 0.0004 |
| 5 | ACLIDINIUM BROMIDE | 2 | 0.0003 |
| 6 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 7 | GUANFACINE | 2 | 0.0002 |
| 8 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 1 | 0.0002 |
| 9 | RITUXIMAB-ABBS | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 18 |
| 1 | Atypical Antipsychotic [EPC] | 10 |
| 2 | Opioid Agonist [EPC] | 7 |
| 3 | Benzodiazepine [EPC] | 5 |
| 4 | Corticosteroid [EPC] | 5 |
| 5 | Androgen [EPC] | 4 |
| 6 | Central Nervous System Stimulant [EPC] | 3 |
| 7 | GLP-1 Receptor Agonist [EPC] | 3 |
| 8 | Anti-epileptic Agent [EPC] | 2 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Partial Opioid Agonist [EPC] | 18 | 0.0002 |
| 2 | Androgen [EPC] | 4 | 0.0001 |
| 3 | Recombinant Human Deoxyribonuclease 1 [EPC] | 2 | 0.0001 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 5 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 6 | Recombinant Human Nerve Growth Factor [EPC] | 1 | 0.0001 |
| 7 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 8 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 9 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |